Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sanofi Ord Shs SNYNF

Healthcare
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood... see more

Recent & Breaking News (OTCPK:SNYNF)

Providing Quality Healthcare Through Long-term Investments, Divestitures, New Research, Clinical Trials Results - Research Report on AmerisourceBergen, Zoetis, AstraZeneca, Cardinal Health and Sanofi

PR Newswire June 12, 2013

New Four-Strain Influenza Vaccine from Sanofi Pasteur Now Licensed By FDA for Broad Age Range of Children and Adults

PR Newswire June 10, 2013

Quebec Star Sprinter & High Tech Knee Simulator Highlight Impact of Knee Pain

Canada NewsWire June 6, 2013

High Tech Knee Simulator Highlights Impact of Knee Pain

Canada NewsWire June 5, 2013

Emmy® Award-Winning Actress Sarah Michelle Gellar Joins March of Dimes and Sanofi Pasteur on the Sounds of Pertussis® Campaign

PR Newswire June 5, 2013

Sanofi US Announces Winner of 2013 Data Design Diabetes Innovation Challenge -- Prove It!

PR Newswire June 4, 2013

Pre-Market Analysis on VVUS, SNY, XRAY, and ACUR

Accesswire June 4, 2013

Genzyme Celebrates Fifth Annual World MS Day

Business Wire May 29, 2013

Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine

PR Newswire May 21, 2013

Sanofi Relies on Axway to Future-Proof their Infrastructure and Reduce Operational Costs through Global Consolidation

Business Wire May 21, 2013

Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis

PR Newswire May 17, 2013

Finding the Next Big Blockbuster Drug

Accesswire May 16, 2013

Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma and Allergy Awareness Month

PR Newswire May 16, 2013

Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)

PR Newswire May 15, 2013

New Gold Bond® No Mess Powder Spray Introduced by Sanofi's Chattem

PR Newswire May 6, 2013

Sanofi US and Actress Elizabeth Perkins Premiere Documentary -- Diabetes Co-Stars Presents "Strength in Numbers"

PR Newswire May 6, 2013

Sanofi: Q1 2013 business EPS(1) impacted by exclusivity losses in prior year

PR Newswire May 2, 2013

Sanofi Q1 2013 - Interview with CFO Jérôme Contamine

Business Wire May 2, 2013

Sanofi Pasteur Scholarships awarded to four HEC Montréal students

Canada NewsWire May 1, 2013

NextBio Announces Translational Medicine Partnership with Sanofi

PR Newswire April 30, 2013